Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant August 2, 2019
Verzenio-Faslodex combo prolongs survival in advanced breast cancer, interim phase 3 data show August 2, 2019
Novartis Kisqali (ribociclib) significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials July 31, 2019
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for HR+ MBC July 2, 2019
Influence of patient & tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study June 21, 2019 0
Palbociclib with letrozole in postmenopausal women with ER+/HER2−neg advanced breast cancer: hematologic safety analysis of the randomized PALOMA-2 trial June 19, 2019